药房考虑资助家庭内尿检,以便进行医疗堕胎后续检查,这有可能取代血液检测。 Pharmac considers funding at-home urine tests for medical abortion follow-up, potentially replacing blood tests.
新西兰的制药供资机构药房正在考虑为家中低敏感性尿检提供资金,以确认医疗堕胎已经完成,可能取代验血。 Pharmac, New Zealand's pharmaceutical funding agency, is considering funding at-home low sensitivity urine tests to confirm the completion of medical abortions, potentially replacing blood tests. 这一变化旨在改善无障碍环境,因为许多个人目前没有完成后续测试。 This change aims to improve accessibility, as many individuals currently do not complete follow-up tests. 如果获得批准,大约9 300人可以在第一年使用这些测试。 If approved, about 9,300 people could use the tests in the first year. 公众咨询持续到10月30日, 可能于2024年12月1日展开。 Public consultation runs until October 30, with a possible rollout on December 1, 2024.